Literature DB >> 19539379

Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis.

Walter Royal1, Younus Mia, Huifen Li, Kerry Naunton.   

Abstract

Vitamin D has been associated with a decreased risk of multiple sclerosis (MS). In this study, serum 1, 25-dihydroxyvitamin D (1, 25-(OH)2 vitD) and 25-hydroxyvitamin D (25-OH vitD), regulatory T cell percentages and naïve and memory T helper cell subsets were measured in 26 patients with multiple sclerosis, 21 who were not on treatment with disease modifying therapy. These studies showed an inverse correlation between 25-OH vitD levels and Treg cell percentages and a direct correlation between Treg cell percentages and 1, 25-(OH)2 vitD:25-OH vitD ratios. In addition, 25-OH vitD levels correlated directly and 1, 25-(OH)2 vitD:25-OH vitD ratios correlated inversely with CXCR3+ naïve T helper cell percentages and CXCR3+naïve:CXCR3+ memory T helper cell ratios. All together, these data demonstrate that vitamin D measurements can reflect measures of immune status among patients with MS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19539379     DOI: 10.1016/j.jneuroim.2009.05.012

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  21 in total

Review 1.  Influence of dietary components on regulatory T cells.

Authors:  Shohreh Issazadeh-Navikas; Roman Teimer; Robert Bockermann
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

Review 2.  Inflammation and adaptive immunity in Parkinson's disease.

Authors:  R Lee Mosley; Jessica A Hutter-Saunders; David K Stone; Howard E Gendelman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

3.  The gut microbiome in multiple sclerosis.

Authors:  Daniel W Mielcarz; Lloyd H Kasper
Journal:  Curr Treat Options Neurol       Date:  2015-04       Impact factor: 3.598

4.  1,25-Dihydroxyvitamin D3 inhibits proliferation but not the suppressive function of regulatory T cells in the absence of antigen-presenting cells.

Authors:  Ai-Leng Khoo; Irma Joosten; Meta Michels; Rob Woestenenk; Frank Preijers; Xue-Hui He; Mihai G Netea; André J A M van der Ven; Hans J P M Koenen
Journal:  Immunology       Date:  2011-12       Impact factor: 7.397

Review 5.  Role of vitamin D in immune responses and autoimmune diseases, with emphasis on its role in multiple sclerosis.

Authors:  Hong-Liang Zhang; Jiang Wu
Journal:  Neurosci Bull       Date:  2010-12       Impact factor: 5.203

Review 6.  Multiple sclerosis and vitamin D: a review and recommendations.

Authors:  Andrew J Solomon; Ruth H Whitham
Journal:  Curr Neurol Neurosci Rep       Date:  2010-09       Impact factor: 5.081

7.  Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation.

Authors:  Charles Pierrot-Deseilligny; Sophie Rivaud-Péchoux; Pierre Clerson; Raphaël de Paz; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2012-07       Impact factor: 6.570

Review 8.  Cancer inflammation and regulatory T cells.

Authors:  Susan E Erdman; Theofilos Poutahidis
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

9.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

10.  Vitamin D supplementation effects on FoxP3 expression in T cells and FoxP3+/IL-17A ratio and clinical course in systemic lupus erythematosus patients: a study in a Portuguese cohort.

Authors:  António Marinho; Cláudia Carvalho; Daniela Boleixa; Andreia Bettencourt; Bárbara Leal; Judite Guimarães; Esmeralda Neves; José Carlos Oliveira; Isabel Almeida; Fátima Farinha; Paulo P Costa; Carlos Vasconcelos; Berta M Silva
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.